Avrobio Inc Expected To Post A Loss Of 36 Cents A Share: Earnings Preview

Tectonic Therapeutic

19/03/2024 13:11

* AVROBIO Inc  AVRO.OQ   AVRO.O  is expected to report
results on
March 21 (estimated) for the period ending March 31 2024
    * 
    * ​LSEG's mean analyst estimate for AVROBIO Inc is for a
loss
of 36 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts had risen by
about 12.6%
in the last three months. ​
    * Wall Street's median 12-month price target for AVROBIO Inc
is
$2.00​, above​ its last closing price of $1.29. ​​​

This summary was machine generated March 19 at 13:11 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)